Immune Cells Release MicroRNA-155 Enriched Extracellular Vesicles That Promote HIV-1 Infection.

HIV-1 TRL7/8 calprotectin extracellular vesicles immune activation inflammation miR-155 micro-RNA pathogenesis

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
31 01 2023
Historique:
received: 26 11 2022
revised: 21 01 2023
accepted: 25 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

The hallmark of HIV-1 infection is the rapid dysregulation of immune functions. Recent investigations for biomarkers of such dysregulation in people living with HIV (PLWH) reveal a strong correlation between viral rebound and immune activation with an increased abundance of extracellular vesicles (EVs) enriched with microRNA-155. We propose that the activation of peripheral blood mononuclear cells (PBMCs) leads to an increased miR-155 expression and production of miR-155-rich extracellular vesicles (miR-155-rich EVs), which can exacerbate HIV-1 infection by promoting viral replication. PBMCs were incubated with either HIV-1 (NL4.3Balenv), a TLR-7/8 agonist, or TNF. EVs were harvested from the cell culture supernatant by differential centrifugation, and RT-qPCR quantified miR-155 in cells and derived EVs. The effect of miR-155-rich EVs on replication of HIV-1 in incubated PBMCs was then measured by viral RNA and DNA quantification. HIV-1, TLR7/8 agonist, and TNF each induced the release of miR-155-rich EVs by PBMCs. These miR-155-rich EVs increased viral replication in PBMCs infected in vitro. Infection with HIV-1 and inflammation promote the production of miR-155-rich EVs, enhancing viral replication. Such autocrine loops, therefore, could influence the course of HIV-1 infection by promoting viral replication.

Identifiants

pubmed: 36766808
pii: cells12030466
doi: 10.3390/cells12030466
pmc: PMC9914104
pii:
doi:

Substances chimiques

MicroRNAs 0
MIRN155 microRNA, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : MOP-391232
Pays : Canada
Organisme : CIHR
ID : MOP-188726
Pays : Canada
Organisme : CIHR
ID : MOP-267056
Pays : Canada

Références

PLoS One. 2014 Jun 30;9(6):e100820
pubmed: 24978053
J Virol. 2009 Jan;83(2):512-21
pubmed: 18987139
Virology. 1999 Jan 5;253(1):10-6
pubmed: 9887314
J Virol. 2014 Oct;88(19):11529-39
pubmed: 25056899
J Clin Microbiol. 2005 Jun;43(6):2709-17
pubmed: 15956387
Cell Mol Neurobiol. 2016 Apr;36(3):301-12
pubmed: 27053351
Cell Microbiol. 2013 Mar;15(3):412-29
pubmed: 23072732
J Immunol. 1989 Jan 15;142(2):431-8
pubmed: 2463307
Pathogens. 2021 Apr 27;10(5):
pubmed: 33925397
Mucosal Immunol. 2016 Jan;9(1):194-205
pubmed: 26104913
J Virol. 1997 Mar;71(3):1922-30
pubmed: 9032323
Traffic. 2010 Jan;11(1):110-22
pubmed: 19912576
Nat Commun. 2020 Jan 10;11(1):214
pubmed: 31924781
J Mol Biol. 2013 Oct 9;425(19):3582-600
pubmed: 23500488
J Extracell Vesicles. 2012 Apr 16;1:
pubmed: 24009886
C R Biol. 2017 Feb;340(2):114-131
pubmed: 28081967
Mol Med Rep. 2017 Aug;16(2):1584-1589
pubmed: 28627655
Eur J Immunol. 2011 Apr;41(4):1058-69
pubmed: 21337543
PLoS One. 2016 Nov 23;11(11):e0167091
pubmed: 27880829
Cells. 2022 Mar 02;11(5):
pubmed: 35269481
Viruses. 2019 Dec 19;12(1):
pubmed: 31861621
Viruses. 2021 Nov 12;13(11):
pubmed: 34835072
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2750-5
pubmed: 17293455
BMC Res Notes. 2017 Aug 14;10(1):403
pubmed: 28807007
J Immunol. 2006 Mar 1;176(5):2888-95
pubmed: 16493046
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9659-E9667
pubmed: 30257946
Front Cell Infect Microbiol. 2012 Jun 01;2:73
pubmed: 22919664
J Biol Chem. 2013 Jul 5;288(27):20014-33
pubmed: 23661700
Arthritis Res Ther. 2011 Apr 14;13(2):R60
pubmed: 21492422
Nat Commun. 2015 Jun 18;6:7321
pubmed: 26084661
J Virol. 2002 Feb;76(3):1004-14
pubmed: 11773376
Mediators Inflamm. 2016;2016:8060182
pubmed: 27843203
Gene. 2013 Dec 10;532(1):1-12
pubmed: 23246696
J Immunol. 2003 Mar 15;170(6):3233-42
pubmed: 12626582
J Antimicrob Chemother. 2014 Nov;69(11):3041-6
pubmed: 25011654
Science. 2001 Oct 26;294(5543):853-8
pubmed: 11679670
J Immunol. 2003 Sep 1;171(5):2435-45
pubmed: 12928391
Blood. 2003 Feb 1;101(3):1024-9
pubmed: 12393488
Adv Exp Med Biol. 2018;1075:213-239
pubmed: 30030795
Microbes Infect. 2012 Mar;14(3):247-61
pubmed: 22064066
Br J Cancer. 2010 Feb 16;102(4):639-44
pubmed: 20087353
J Clin Invest. 2012 Nov;122(11):4190-202
pubmed: 23041630
Free Radic Biol Med. 2017 Mar;104:185-198
pubmed: 28087411
HIV Med. 2017 May;18(5):354-362
pubmed: 27981723
Oncogene. 2016 Nov 3;35(44):5735-5745
pubmed: 27086923
Retrovirology. 2018 Oct 23;15(1):71
pubmed: 30352600
J Clin Invest. 2019 Feb 1;129(2):712-726
pubmed: 30640176
Cold Spring Harb Protoc. 2010 Jun;2010(6):pdb.prot5439
pubmed: 20516177
Pathog Immun. 2021 Jan 14;6(1):1-28
pubmed: 33987483
Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):
pubmed: 28716890
Front Immunol. 2021 Jan 18;11:617522
pubmed: 33537035
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2365-8
pubmed: 2784570
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
J Leukoc Biol. 2004 Aug;76(2):433-40
pubmed: 15107458
AIDS. 2014 Jan 14;28(2):171-80
pubmed: 24413309
Eur J Immunol. 2008 Feb;38(2):400-9
pubmed: 18228247
Blood. 2008 Jan 15;111(2):699-704
pubmed: 17909079
J Infect Dis. 2015 Jun 1;211(11):1712-6
pubmed: 25512626
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20047-52
pubmed: 23169640
Cell. 2007 Jun 29;129(7):1401-14
pubmed: 17604727
Leukemia. 2014 Dec;28(12):2324-35
pubmed: 24727676
Mol Cell Proteomics. 2019 Mar;18(3):461-476
pubmed: 30504243
Sci Rep. 2018 May 8;8(1):7227
pubmed: 29740045
Mol Biol Rep. 2022 Aug;49(8):7783-7792
pubmed: 35733067
Front Immunol. 2022 Aug 29;13:916599
pubmed: 36105810
J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):219-27
pubmed: 26181817
Virol J. 2007 Dec 03;4:130
pubmed: 18053162
J Biol Chem. 2015 May 29;290(22):13736-48
pubmed: 25873391
AIDS Res Hum Retroviruses. 2011 Feb;27(2):167-78
pubmed: 20964480
J Virol. 2018 May 29;92(12):
pubmed: 29593039
J Interferon Cytokine Res. 2019 Jun;39(6):321-330
pubmed: 30998423
Biol Chem. 2018 May 24;399(6):525-547
pubmed: 29447113
J Immunol Res. 2015;2015:296149
pubmed: 27057553
J Biol Chem. 2017 Dec 15;292(50):20683-20693
pubmed: 29066622
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7113-8
pubmed: 19359473
PLoS Genet. 2021 Dec 6;17(12):e1009951
pubmed: 34871319
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
pubmed: 16885212
Sci Rep. 2017 May 10;7(1):1695
pubmed: 28490736
J Immunol. 2012 Jul 15;189(2):744-54
pubmed: 22711894
Int J Biol Sci. 2019 Nov 15;15(13):2925-2935
pubmed: 31853228
Nucleic Acids Res. 2012 Apr;40(8):3548-62
pubmed: 22187158
J Virol. 2014 Nov;88(21):12385-96
pubmed: 25122785
J Immunol Methods. 2003 Sep;280(1-2):1-11
pubmed: 12972183

Auteurs

Julien Boucher (J)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.

Alyssa Rousseau (A)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.

Catherine Boucher (C)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.

Caroline Subra (C)

U.S. Military HIV Research Program, Silver Spring, MD 20910, USA.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA.
Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA.

Wilfried W Bazié (WW)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.
Programme de Recherche sur les Maladies Infectieuses, Centre Muraz, Institut National de Santé Publique, Bobo-Dioulasso 01 BP 390, Burkina Faso.

Audrey Hubert (A)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.

Emma Bourgeault (E)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.

Abderrahim Benmoussa (A)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.

Benjamin Goyer (B)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.

Philippe A Tessier (PA)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.
Département de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.

Caroline Gilbert (C)

Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.
Département de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH